SK Chemicals, Institutional Investors Sold Net 32,960 Shares in Last 5 Days... Stock Price at 418,000 KRW (+0.6%)

As of 9:30 AM on the 3rd, SK Chemicals is trading at 418,000 KRW, up 0.6% from the previous day. The trading volume is 44,961 shares, which is about 13.54% of the previous day's volume. SK Chemicals is known as a manufacturer of eco-friendly materials, energy, and biopharmaceuticals.

On September 1st, researcher Dalmi Lee from SK Securities stated, "Due to COVID-19, SK Chemicals has secured CMO orders from AstraZeneca and Novavax, increasing the value of its vaccines. Production of AstraZeneca's volume began in Q3 2020, expected to drive vaccine performance. Additionally, with increased demand for flu vaccines, Q3 2020 vaccine performance is expected to reach an all-time high. It is also anticipated that the clinical phase 3 results from client companies will be promising. The subsidiary, SK Bioscience, is scheduled to go public next year, which could lead to further value appreciation." He set SK Chemicals' target price at 500,000 KRW.

Over the past five days, individual investors have net purchased 26,358 shares of SK Chemicals, while foreigners and institutions have net purchased 6,886 shares and net sold 32,960 shares, respectively.

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.